Nano-herb medicine and PDT induced synergistic immunotherapy for colon cancer treatment

Xiaoli Wu,Han Yang,Xingmeng Chen,Junxiao Gao,Yue Duan,Daohe Wei,Jinchao Zhang,Kun Ge,Xing-Jie Liang,Yuanyu Huang,Sizhou Feng,Rongli Zhang,Xi Chen,Jin Chang
DOI: https://doi.org/10.1016/j.biomaterials.2021.120654
IF: 14
2021-02-01
Biomaterials
Abstract:<p>A variety of therapies have been developed and used for the treatment of colon cancer, however, the high mortality rate remains high and more effective strategies are still in urgent needs. In this study, an immunotherapy approach that is composed of innate immune activator Astragaloside III (As) and the photodynamic therapy (PDT) reagent chlorine e6 (Ce6) ((As+Ce6)@MSNs-PEG), was developed for colon cancer treatment. We showed that (As+Ce6)@MSNs-PEG could effectively activate NK cells and inhibit the proliferation of tumor cells <em>in vitro</em>. It could also effectively reach tumor sites, induce infiltration of immune cells into the tumor, and enhance the cytotoxicity of natural killer cells and CD8<sup>+</sup> T cells <em>in vivo</em>. Without obvious side effects, (As+Ce6)@MSNs-PEG treatment significantly inhibited tumor growth and extended the lifespan of tumor-bearing mice. Further results revealed that treatment of (As+Ce6)@MSNs-PEG led to enhanced IFN secretion by immune cells and increased T-box transcription factor (T-bet), which is highly expressed by T cells. Therefore, (As+Ce6)@MSNs-PEG may serve as an effective and safe platform for combinatory use with nano-herb medicine and PDT to provide a new therapy for colon cancer treatment.</p>
engineering, biomedical,materials science, biomaterials
What problem does this paper attempt to address?